CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-12-19 | LINDSTROM RICHARD L MD Director | Purchase · Purchase Warrant | +100,000 | $0.13 | $13K | 100,000 |
| 2016-12-19 | BOLL ANDREW R. Chief Financial Officer | Purchase | +39,000 | $1.79 | $70K | 54,000 |
| 2016-12-19 | BOLL ANDREW R. Chief Financial Officer | Purchase · Purchase Warrant | +39,000 | $0.13 | $5K | 39,000 |
| 2016-12-19 | BAUM MARK L Chief Executive Officer | Purchase | +156,000 | $1.79 | $279K | 325,835 |
| 2016-12-19 | BAUM MARK L Chief Executive Officer | Option exercise | +200,000 | $1.72 | $344K | 525,835 |
| 2016-12-19 | BAUM MARK L Chief Executive Officer | Returned to the company | −83,709 | $1.72 | $144K | 442,126 |
| 2016-12-19 | BAUM MARK L Chief Executive Officer | Purchase · Purchase Warrant | +156,000 | $0.13 | $20K | 156,000 |
| 2016-12-19 | BAUM MARK L Chief Executive Officer | Option exercise · Restricted Stock Unit | −200,000 | 0 | ||
| 2016-11-02 | Kammer Robert J Director | Other acquisition | +95,000 | $4.58 | $435K | 1,089,827 |
| 2016-06-10 | Principi Anthony Director | Grant or award · RSU | +12,690 | 12,690 | ||
| 2016-06-10 | Nelson William H. Director | Grant or award · RSU | +12,690 | 12,690 | ||
| 2016-06-10 | LINDSTROM RICHARD L MD Director | Grant or award · RSU | +12,690 | 12,690 | ||
| 2016-06-10 | Kammer Robert J Director | Grant or award · RSU | +12,690 | 12,690 | ||
| 2016-06-10 | AUSTIN STEPHEN G Director | Grant or award · RSU | +12,690 | 12,690 | ||
| 2016-04-25 | BOLL ANDREW R. Chief Financial Officer | Grant or award · Executive RSU | +157,500 | 157,500 | ||
| 2016-04-25 | BOLL ANDREW R. Chief Financial Officer | Returned to the company · Executive RSU | −157,500 | 0 | ||
| 2016-04-25 | BAUM MARK L Chief Executive Officer | Grant or award · Executive RSU | +1,050,000 | 1,050,000 | ||
| 2016-04-25 | BAUM MARK L Chief Executive Officer | Returned to the company · Executive RSU | −1,050,000 | 0 | ||
| 2016-04-01 | SAHAREK JOHN P. Chief Commercial Officer | Grant or award · Option - Right to Buy | +60,000 | 60,000 | ||
| 2016-04-01 | BOLL ANDREW R. Chief Financial Officer | Grant or award · Option - Right to Buy | +60,000 | 60,000 |
Page 16 of 17 · 336 trades